Published in Virology on December 01, 1970
Chromatographic separation and antigenic analysis of proteins of the oncornaviruses. I. Avian leukemia-sarcoma viruses. J Virol (1971) 4.80
Identification of a large polypeptide precursor of avian oncornavirus proteins. Proc Natl Acad Sci U S A (1973) 3.07
Chromatographic separation and antigenic analysis of proteins of the oncornaviruses. II. Mammalian leukemia-sarcoma viruses. J Virol (1972) 2.84
Structural studies of avian myeloblastosis virus: comparison of polypeptides in virion and core component by dodecyl sulfate-polyacrylamide gel electrophoresis. J Virol (1974) 2.79
Rabies group-specific ribonucleoprotein antigen and a test system for grouping and typing of rhabdoviruses. J Virol (1973) 2.40
Subunit structure of the glycoprotein complex of avian tumor virus. J Virol (1976) 2.38
Quantitation of avian RNA tumor virus reverse transcriptase by radioimmunoassay. J Virol (1975) 2.27
The binding of an avian myeloblastosis virus basic 12,000 dalton protein to nucleic acids. Nucleic Acids Res (1979) 1.80
Proteins of hepatitis B surface antigen. J Virol (1977) 1.71
Production and purification of large amounts of Rous sarcoma virus. Appl Microbiol (1973) 1.66
Analysis of high-molecular-weight ribonucleic acid associated with intracisternal A particles. J Virol (1973) 1.55
Translation of avian myeloblastosis virus RNA in a cell-free lysate of Escherichia coli. Proc Natl Acad Sci U S A (1972) 1.53
Properties of feline leukemia virus. I. Chromatographic separation and analysis of the polypeptides. J Virol (1974) 1.51
Immunological studies on viral polypeptide synthesis in cells replicating murine sarcoma-leukemia virus. J Virol (1972) 1.44
Calcium-dependent regulatory protein of cyclic nucleotide metabolism in normal and transformed chicken embryo fibroblasts. Proc Natl Acad Sci U S A (1976) 1.43
Radioimmunoassay for avian C-type virus group-specific antigen: detection in normal and virus-transformed cells. J Virol (1973) 1.34
Role of carbohydrate in determining the immunochemical properties of the major glycoprotein (gp71) of Friend murine leukemia virus. J Virol (1975) 1.06
Serological characterization of the three major proteins of vesicular stomatitis virus. J Virol (1974) 1.05
Anomalous behavior of the major avian myeloblastosis virus glycoprotein in the presence of sodium dodecyl sulfate. J Virol (1978) 0.98
Pathology of chickens infected with avian nephoblastoma virus MAV-2(N). Infect Immun (1980) 0.96
Effect of trypsin on mouse mammary tumor virus. J Virol (1976) 0.96
Substructures and polypeptides of Visna virus. J Virol (1974) 0.93
Polyacrylamide gel electrophoresis of visna virus polypeptides isolated by agarose gel chromatography. J Virol (1978) 0.91
Proteins of bovine leukemia virus. I. Characterization and reactions with natural antibodies. J Virol (1977) 0.89
Immunoelectrophoretic analysis of avian ribonucleic acid tumor virus group-specific antigens. J Virol (1972) 0.86
Large-scale purification of ribonucleic acid tumor viruses by use of continuous-flow density gradient centrifugation. Appl Microbiol (1973) 0.85
Viral protein sythesis by tissues from avian leukosis virus-infected chickens. II. Effect of passive neutralizing antibody in normal and agammaglobulinaemic chickens. Immunology (1979) 0.81
Intracytoplasmic type A particles from mammary tumours and leukaemias of strain ICRC mice. Br J Cancer (1979) 0.80
Reactivity of avian RNA tumor viruses with lectins. J Virol (1975) 0.78
Outer membrane of avian myeloblastosis virus. J Virol (1973) 0.78
Activating and protective capacities of a purified electrophoretic fraction of murine leukemia virus for murine leukemia virus infectivity. Proc Natl Acad Sci U S A (1972) 0.78
Phosphorylation of 3'-azido-3'-deoxythymidine and selective interaction of the 5'-triphosphate with human immunodeficiency virus reverse transcriptase. Proc Natl Acad Sci U S A (1986) 8.48
Type-specific neutralization of the human immunodeficiency virus with antibodies to env-encoded synthetic peptides. Proc Natl Acad Sci U S A (1988) 7.74
Principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein. Proc Natl Acad Sci U S A (1989) 6.58
A novel murine oncornavirus with dual eco- and xenotropic properties. Proc Natl Acad Sci U S A (1975) 5.91
Prospect for prevention of human immunodeficiency virus infection: purified 120-kDa envelope glycoprotein induces neutralizing antibody. Proc Natl Acad Sci U S A (1986) 5.55
A proposed nomenclature for the virion proteins of oncogenic RNA viruses. Virology (1974) 5.01
Conserving large carnivores: dollars and fence. Ecol Lett (2013) 4.84
Restricted neutralization of divergent human T-lymphotropic virus type III isolates by antibodies to the major envelope glycoprotein. Proc Natl Acad Sci U S A (1986) 4.68
Broadly neutralizing antibodies elicited by the hypervariable neutralizing determinant of HIV-1. Science (1990) 4.43
Neutralizing antibodies to an immunodominant envelope sequence do not prevent gp120 binding to CD4. J Virol (1988) 4.13
Association of viral reverse transcriptase with an enzyme degrading the RNA moiety of RNA-DNA hybrids. Nat New Biol (1971) 3.95
Efficacy and safety of thrombolytic therapy after initially unsuccessful cardiopulmonary resuscitation: a prospective clinical trial. Lancet (2001) 3.88
Assembly of type C oncornaviruses: a model. Science (1978) 3.53
Interaction between the human T-cell lymphotropic virus type IIIB envelope glycoprotein gp120 and the surface antigen CD4: role of carbohydrate in binding and cell fusion. Proc Natl Acad Sci U S A (1987) 3.47
Neutralizing antibody responses to human immunodeficiency virus type 1 in primary infection and long-term-nonprogressive infection. J Infect Dis (1997) 3.35
Src Gene product from different strains of avian sarcoma virus: Kinetics and possible mechanism of heat inactivation of protein kinase activity from cells infected by transformation-defective, temperature-sensitive mutant and wild-type virus. Proc Natl Acad Sci U S A (1979) 3.20
A molecular clasp in the human immunodeficiency virus (HIV) type 1 TM protein determines the anti-HIV activity of gp41 derivatives: implication for viral fusion. J Virol (1995) 3.11
Clade B-based HIV-1 vaccines elicit cross-clade cytotoxic T lymphocyte reactivities in uninfected volunteers. Proc Natl Acad Sci U S A (1997) 3.02
Localization of RNA tumor virus polypeptides. I. Isolation of further virus substructures. Virology (1973) 2.94
Transoesophageal echocardiography shows high risk of gas embolism during laparoscopic hepatic resection under carbon dioxide pneumoperitoneum. Br J Surg (2002) 2.61
Human T-cell lymphotropic virus IIIB glycoprotein (gp120) bound to CD4 determinants on normal lymphocytes and expressed by infected cells serves as target for immune attack. Proc Natl Acad Sci U S A (1987) 2.53
Ribonucleic acid components of BAI strain A (myeloblastosis) avian tumor virus. Cancer Res (1967) 2.53
Substitution of the thioredoxin system for glutathione reductase in Drosophila melanogaster. Science (2001) 2.40
Early changes in the distribution and organization of microfilament proteins during cell transformation. Cell (1981) 2.25
Isolation of the major viral glycoprotein and a putative precursor from cells transformed by avian sarcoma viruses. Proc Natl Acad Sci U S A (1974) 2.15
Oncogenicity of non-transforming mutants of avian sarcoma viruses. J Gen Virol (1973) 2.14
Polypeptides of avian RNA tumor viruses. IV. Components of the viral envelope. Virology (1972) 2.09
The principal neutralization determinant of simian immunodeficiency virus differs from that of human immunodeficiency virus type 1. Proc Natl Acad Sci U S A (1992) 2.00
Antibodies against synthetic peptides as a tool for functional analysis of the transforming protein pp60src. Cell (1983) 1.91
A conserved region at the COOH terminus of human immunodeficiency virus gp120 envelope protein contains an immunodominant epitope. Proc Natl Acad Sci U S A (1987) 1.87
Defective cleavage of a precursor polypeptide in a temperature-sensitive mutant of avian sarcoma virus. Virology (1976) 1.82
Distinguishable transformation-defective phenotypes among temperature-sensitive mutants of Rous sarcoma virus. J Virol (1977) 1.79
Neutralization of homologous and heterologous oncornaviruses by antisera against the p15(E) and gp71 polypeptides of Friend murine leukemia virus. Virology (1976) 1.73
Evidence that a precursor glycoprotein is cleaved to yield the major glycoprotein of avian tumor virus. J Virol (1977) 1.70
Humoral immune response to the entire human immunodeficiency virus envelope glycoprotein made in insect cells. Proc Natl Acad Sci U S A (1987) 1.70
Isolation of proteins by gel filtration in 6M guanidinium chloride: application to RNA tumor viruses. Anal Biochem (1974) 1.70
Identification of sites within gp41 that serve as targets for antibody-dependent cellular cytotoxicity by using human monoclonal antibodies. J Immunol (1990) 1.68
Augmentation of human immunodeficiency virus type 1 neutralizing antibody by priming with gp160 recombinant vaccinia and boosting with rgp160 in vaccinia-naive adults. The NIAID AIDS Vaccine Clinical Trials Network. J Infect Dis (1993) 1.67
Phenotypic variation in the response to the human immunodeficiency virus among derivatives of the CEM T and WIL-2 B cell lines. J Exp Med (1988) 1.67
CD8+ T lymphocyte-mediated inhibition of HIV-1 long terminal repeat transcription: a novel antiviral mechanism. AIDS Res Hum Retroviruses (1993) 1.66
Osteosarcoma over the age of forty. Eur J Cancer (2003) 1.65
An analysis of type-C retrovirus polypeptides and their associations in the virion. Virology (1978) 1.65
Comparative chemical properties of avian oncornavirus polypeptides. Virology (1975) 1.64
Polypeptides of mammalian oncornaviruses. II Characterization of murine leukemia virus polypeptide (p 15) bearing interspecies reactivity. Virology (1975) 1.63
Studies on mouse leukemia viruses. I. Isolation and characterization of a group-specific antigen. Virology (1969) 1.63
Polyvalent human immunodeficiency virus synthetic immunogen comprised of envelope gp120 T helper cell sites and B cell neutralization epitopes. J Immunol (1989) 1.63
California arbovirus (La Crosse) infections. I. Clinical and laboratory findings in 66 children with meningoencephalitis. Pediatrics (1973) 1.62
Polypeptides of mammalian oncornaviruses. I. Isolation and serological analysis polypeptides from murine and feline C-type viruses. Virology (1973) 1.59
HIV-1 GP120-mediated immune suppression and lymphocyte destruction in the absence of viral infection. J Immunol (1989) 1.57
Purification and serological characterization of the major envelope glycoprotein from AKR murine leukemia virus and its reactivity with autogenous immune sera from mice. J Virol (1976) 1.56
Colloidal gold granules as markers for cell surface receptors in the scanning electron microscope. Experientia (1975) 1.55
Cerebral and extracerebral release of protein S100B in cardiac surgical patients. Anaesthesia (2004) 1.55
Expression of murine leukemia virus structural antigens on the surface of chemically induced murine sarcomas. Proc Natl Acad Sci U S A (1974) 1.54
Cardiac output measurement by transpulmonary versus conventional thermodilution technique in intensive care patients after coronary artery bypass grafting. J Cardiothorac Vasc Anesth (1998) 1.54
Translation of avian myeloblastosis virus RNA in a cell-free lysate of Escherichia coli. Proc Natl Acad Sci U S A (1972) 1.53
Polypeptides of avian RNA tumor viruses. V. Analysis of the virus core. Virology (1972) 1.51
Polypeptides of mammalian oncornaviruses. III. Localization of p 15 and reactivity with natural antibody. Virology (1975) 1.48
Expression of the Major Viral Glycoprotein of Avian Tumor Virus in Cells of chf(+) Chicken Embryos. J Virol (1975) 1.48
The impact of 3-dimensional reconstructions on operation planning in liver surgery. Arch Surg (2000) 1.47
Serological responses in chimpanzees inoculated with human immunodeficiency virus glycoprotein (gp120) subunit vaccine. Proc Natl Acad Sci U S A (1987) 1.46
In search of the astrocytic factor(s) modulating blood-brain barrier functions in brain capillary endothelial cells in vitro. Cell Mol Neurobiol (2005) 1.46
Origin of group-specific antigen of chicken leukosis viruses. Virology (1966) 1.44
Evidence that antibody-mediated neutralization of human immunodeficiency virus type 1 by sera from infected individuals is independent of coreceptor usage. J Virol (1998) 1.43
Biological, immunological, and biochemical evidence that HIX virus is a recombinant between Moloney leukemia virus and a murine xenotropic C type virus. Virology (1978) 1.42
Macrophage accumulation in mice is inhibited by low molecular weight products from murine leukemia viruses. J Immunol (1980) 1.41
Isolation and characterization of two group-specific antigens from feline leukemia virus. Virology (1971) 1.41
Operative reconstruction of the external and internal genitalia in female patients with bladder exstrophy or incontinent epispadias. J Urol (1995) 1.41
Identification of human T cell leukemia virus in a Japanese patient with adult T cell leukemia and cutaneous lymphomatous vasculitis. Proc Natl Acad Sci U S A (1983) 1.41
Cellular anti-GP120 cytolytic reactivities in HIV-1 seropositive individuals. Lancet (1988) 1.38
Structural components of rna tumor viruses. Adv Virus Res (1974) 1.37
Oncogenic and immunogenic potential of cloned HIX virus in mice and cats. Med Microbiol Immunol (1977) 1.37
Familial thymic aplasia. Attempted reconstitution with fetal thymus in a Millipore diffusion chamber. N Engl J Med (1972) 1.37
The enhancing effect of the microbial flora on macrophage function and the immune response. A study in germfree mice. J Exp Med (1966) 1.33
Polypeptides of avian RNA tumor viruses. II. Serological characterization. Virology (1970) 1.32
Response of bone marrow to MC29 avian leukosis virus in vitro. Cancer Res (1969) 1.30
Disseminated strongyloidiasis with cerebral involvement. A complication of corticosteroid therapy. Am J Med (1973) 1.30
Polypeptides of mammalian oncornaviruses. IV. Structural components of murine leukemia virus released as soluble antigens in cell culture. Virology (1975) 1.30
GP120 specific cellular cytotoxicity in HIV-1 seropositive individuals. Evidence for circulating CD16+ effector cells armed in vivo with cytophilic antibody. J Immunol (1989) 1.29
Changes in bioactive lipids, alkylacylglycerol and ceramide, occur in HIV-infected cells. Biochem Biophys Res Commun (1992) 1.29
Group-specific antigenic determinants of the large envelope glycoprotein of avian oncornaviruses. Virology (1975) 1.29
Structural rearrangements in the transmembrane glycoprotein after receptor binding. Immunol Rev (1994) 1.29
In vitro chick embryo cell response to strain MC29 avian leukosis virus. J Virol (1968) 1.26
Isolation of a transplantable cell line induced by the MC29 avian leukosis virus. Cancer Res (1974) 1.25
Immunological properties of avian oncornavirus polypeptides. Virology (1975) 1.25
Neovascularization and the appearance of morphological characteristics of the blood-brain barrier in the embryonic mouse central nervous system. Brain Res Dev Brain Res (1993) 1.24
Human immunodeficiency virus type 1 protease inhibitors irreversibly block infectivity of purified virions from chronically infected cells. Antimicrob Agents Chemother (1992) 1.24
Localization of alkaline phosphatase in Saccharomyces cerevisiae by means of ultrathin frozen sections. J Ultrastruct Res (1975) 1.24
The ability of certain SIV vaccines to provoke reactions against normal cells. Science (1992) 1.22
Essential role of Bmp7 (snailhouse) and its prodomain in dorsoventral patterning of the zebrafish embryo. Development (2000) 1.22
Strain-specific antigen of the avian leukosis sarcoma virus group. I. Isolation and immunological characterization. Virology (1970) 1.22
Ribosomal RNA in avian leukosis virus particles. Int J Cancer (1971) 1.22